Soleo Connect®
Patient Education
Bill Pay
Search for:
About
Company
About Our Company
Leadership
Careers
News
Blogs
Our Locations
Serving You Wherever You Are
See All
Who We Serve
We Serve
Patients
Getting Started
Patient Education
Patient Stories
Providers
Pharma
Clinical Abstracts and Case Studies
Payors
Health Systems
Therapeutics
Conditions Treated
Rare and Orphan Diseases
Allergy and Asthma
Anti-Infective Therapy
Bleeding Disorders
Factor X Deficiency
Cardiovascular
Chronic Inflammatory Disorders
Rheumatoid Arthritis
Gastrointestinal
Crohn’s Disease and Ulcerative Colitis
Nutrition Support
Immunoglobulin Therapy
Primary Immunodeficiency
Neurological Disorders
Alzheimer’s Disease
GBS and CIDP
Multiple Sclerosis
Myasthenia Gravis
Ophthalmologic Conditions
Thyroid Eye Disease
Referrals
See All
Drug List
See all
SoleoRare™
Locations
Referrals
Careers
Contact Us
Home
Who We Serve
Patients
Daisy Award
Drug List
Patient Education
Patient Stories
Providers
Pharma
Clinical Abstracts and Case Studies
SoleMetrics®
Payors
Health Systems
Therapeutics
Rare Diseases
Myositis
Plasminogen Deficiency
Allergy and Asthma
Anti-Infective Therapy
Bleeding Disorders
Factor X Deficiency
Cardiovascular
Chronic Inflammatory Disorders
Rheumatoid Arthritis
Immunoglobulin Therapy
Primary Immunodeficiency
Gastrointestinal
Crohn’s Disease and Ulcerative Colitis
Nutrition Support
Neurological Disorders
Alzheimer’s Disease
GBS and CIDP
Myasthenia Gravis
Multiple Sclerosis
Ophthalmologic Conditions
Thyroid Eye Disease Treatment
Referrals
See All
Drug List
Locations
About
About Our Company
Leadership
News
Blogs
SoleoRare
Careers
Bill Pay
Soleo Connect®
Referrals
Contact Us
Search for:
April 20, 2026
Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, a Specialty Pharmacy Focused on Complex Patient Needs
Read More
Search
Category
All Categories
Abstracts/Posters/Research
Accreditations
Anniversary
Awards
New Leader
New Location
New Partnership
New Product
New Service
Partnership
Uncategorized
July 26, 2022
Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO®
Read More
June 7, 2022
Soleo Health Named a Limited Drug Distribution Partner by Mitsubishi Tanabe Pharma America for RADICAVA ORS®
Read More
June 6, 2022
Soleo Health Named to Genentech’s Limited Drug Distribution Network for Provision of ENSPRYNG®
Read More
May 13, 2022
Soleo Health Earns Five Stevie® Awards in 2022 American Business Awards®
Read More
April 20, 2022
Soleo Health Earns Specialty Pharmacy Reaccreditation From URAC
Read More
March 16, 2022
Soleo Health Urges US Department of Health & Human Services to Provide Patients Access to Monoclonal Antibodies for Treatment of Alzheimer’s Disease
Read More
January 31, 2022
Soleo Health Receives Accreditation as Specialty Pharmacy With Distinction in Rare Disease and Orphan Drugs From Accreditation Commission for Health Care
Read More
January 24, 2022
Soleo Health Selected as Limited Distribution Partner for VYVGART™
Read More
January 11, 2022
Soleo Health to Administer OXLUMO™ for the Treatment of Primary Hyperoxaluria Type 1
Read More
October 5, 2021
Soleo Health Philadelphia Earns Prestigious URAC Accreditation
Read More
No results were found for the selected filters.
Load More